Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection	Chronic Disease, Digestive System Diseases, Disease Attributes, Hepatitis D, Chronic, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, hepatitis, hepatitis D virus infection, liver disorder, viral hepatitis, viral infectious disease	Active, not recruiting	Not applicable	2026-03-03		NCT06603311

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
German Liver Foundation (DLS)	2
Hannover Medical School	52
HepNet Study House, German Liverfoundation	1

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Charité - University Hospital Berlin (Campus Virchow-Clinic); Department of Hepatology and Gastroenterology	Berlin	Germany	1
Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico; Division of Gastroenterology and Hepatology	Milan	Italy	1
Hannover Medical School; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology	Hanover	Germany	1
University Hospital Frankfurt; Medical Clinic 1	Frankfurt am Main	Germany	1
University Hospital Heidelberg; Department of Internal Medicine IV: Gastroenterology, Hepatology, Infectious Diseases, Poisoning	Heidelberg	Germany	1